Image Point Fr - Shutterstock
Image courtesy of Shutterstock
University of Oxford research into a new and better treatment for diabetes has been boosted by a major grant. The DRIVE (Diabetes Reversing Implants with enhanced Viability and long-term Efficacy) consortium, which involves fourteen partners from seven European countries, has received €8.9 million (£6.37 million) funding from the European Union’s Horizon 2020 - Research and Innovation Framework Programme. The programme will develop natural materials and new surgical devices to enhance the transplant and survival of insulin producing pancreatic islets for the treatment of diabetes.